Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Neither BPC-157 nor TB-500 has received FDA approval for human use, placing them in the category of research compounds without official safety data in humans
These might represent the general therapeutic effect on the muscle and the healing and functions recovery (and also tendon [58,59,94,95,96,97], ligament [98] and bone [99,100,101])
However, you may want to take more or less, depending on your age, lifestyle or health needs
Common adverse effects include: Injection site reactions pain, redness, swelling, or bruising at the intramuscular injection site Gastrointestinal disturbances nausea, diarrhoea, or abdominal discomfort Headache and dizziness particularly following initial doses Skin reactions including rash, pruritus, or acne-like eruptions Flushing temporary redness of the skin Chromaturia red-coloured urine (harmless but can cause concern if unexpected) Less common but more serious reactions include: Hypersensitivity reactions ranging from mild urticaria to anaphylaxis (rare but potentially life-threatening) Hypokalaemia particularly during initial treatment when rapid cell production occurs [5] [16] Temporary changes in blood counts during correction of deficiency Interference with laboratory tests primarily with high-dose IV hydroxocobalamin used for cyanide poisoning, not typically with standard 1mg IM replacement doses Cautions and contraindications: Hypersensitivity to cobalt or vitamin B12 Cyanocobalamin should be avoided in Leber's hereditary optic neuropathy [2] [17] Chloramphenicol may reduce the haematological response to B12 therapy Patients receiving B12 injections outside clinical necessity face unnecessary risks without proven benefit
US$ 21.50
US$ 29.70
US$ 20.26
US$ 23.87
US$ 20.89
US$ 26.54
US$ 28.13
US$ 25.09
US$ 26.86
US$ 27.92
US$ 23.55